close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

10.93 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 10.93
Bid (Size) 10.78 (100)
Ask (Size) 11.99 (100)
Prev. Close 10.93
Today's Range 10.93 - 10.93
52wk Range 9.104 - 309.60
Shares Outstanding 75,993,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension
From Gossamer Bio, Inc.
Via Business Wire

Performance

YTD
-95.3%
-95.3%
1 Month
-18.4%
-18.4%
3 Month
-21.1%
-21.1%
6 Month
-63.1%
-63.1%
1 Year
-94.5%
-94.5%

More News

Read More
News headline image
Gossamer Bio Appoints Greg Ciongoli to Board of Directors
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces 1-for-80 Reverse Stock Split
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio to Present at Cantor Global Healthcare Conference
From Gossamer Bio, Inc.
Via Business Wire
Friday's session: most active stocks ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
News headline image
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
From Gossamer Bio, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase
Via AB Newswire
Topics Artificial Intelligence
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
Top movers in Monday's after hours session ↗
Via Chartmill
Which stocks are moving on Monday? ↗
Via Chartmill
Curious about the most active stocks on Monday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
Monday's session: top gainers and losers ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update
From Gossamer Bio, Inc.
Via Business Wire
Top movers in Monday's after hours session ↗
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
From Gossamer Bio, Inc.
Via Business Wire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?
Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.
What exchange does Gossamer Bio, Inc. - Common Stock trade on?
Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?
The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market
What is the current price of Gossamer Bio, Inc. - Common Stock?
The current price of Gossamer Bio, Inc. - Common Stock is 10.93
When was Gossamer Bio, Inc. - Common Stock last traded?
The last trade of Gossamer Bio, Inc. - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of Gossamer Bio, Inc. - Common Stock?
The market capitalization of Gossamer Bio, Inc. - Common Stock is 830.61M
How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?
Gossamer Bio, Inc. - Common Stock has 831M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.